Dr. Hortensia Ferrero is a full-time investigador at IIS La Fe-FIVI through a Miguel Servet contract of the Natitonal Institute of Health Carlos III (ISCIII) 2021-2026 and research group leader for treatment and diagnosis of uterine diseases at IVI Foundation in Valencia. She obtained her Bachelors degree form the University of Valencia in 2006, with a major in Biology. She then obtained a Master’s Degree in Biotechnology and Biomedicine (2008), focusing on Human Reproductive Biology. She carried out her PhD studies with a PFIS fellowship granted by Health Institute Carlos III. In 2013, she worked six months with Dr. D. Stephen Charnock-Jones’ group at University of Cambridge in the Department of Obstetrics and Gynaecology, in the UK, supported by a grant by Health Institute Carlos III. She received her PhD degree in Biotechnology with special international mention, in 2014 from University of Valencia. Her thesis project on the angiogenic process regulating the corpus luteum in physiological and pathological conditions recieved an Extraordinary Award in 2015.
Sara Borrell Grant by Heath Institute Carlos III | 2016-2019 |
PFIS felowship Grant by Heath Institute Carlos III | 2009-2013 |
SRI Travel Award for “NGS of oocytes from endometriosis patients reveals a differential transcriptomic pattern" | 2019 |
Miguel Servet contract (CP20/00120) by Heath Institute Carlos III | 2021-2026 |
SRI President’s Award for Proteomic Analysis of Extracellular Vesicles Secreted by Primary Endometrial Epithelial Cells fromvFertile Women Reveals Functions Related to Embryo Implantation Not Present in an Endometrial Epithelial Cell Line | 2021 |
Exemplary reviewer Award by Fertility and Sterility | 2018 |
PhD Extraordinary Award | 2017 |
ASRM – Endometriosis SIG Prize Paper-Best in Basic Science for “Human blastocysts uptake extracellular vesicles secreted by primary endometrial epithelial cells containing miRNAs related to implantation and early embryo development” | 2022 |
SRI Bayer Discovery/Innovation Grant for “Study of molecular mechanisms related to insulin and progesterone resistance that influence on endometrial receptivity in patients with adenomyosis” | 2022-2023 |
SRI President’s Presenter’s Award for “Doxercalciferol Decreases Uterine Fibroid Growth Rate Through the Regulation of ECM Synthesis and Cell Proliferation | 2023 |